摘要
目的:评估中西医结合治疗与单纯西医治疗非增殖期糖尿病视网膜病变(non-proliferative diabetic retinopathy,NPDR)早期患者的临床疗效。方法:选取我院2014-01/2015-05收治的糖尿病视网膜病变患者中符合标准的患者235例430眼,依据患者入院时间随机分组,观察组110例216眼,予以复方血栓通联合羟苯磺酸钙治疗;对照组125例214眼,仅给予羟苯磺酸钙治疗。患者治疗3mo后,依据视力、眼底情况等方面评估两组患者的临床疗效。结果:观察组中,总有效率为90.3%(195/216),显著高于对照组72.9%(156/214),差异有统计学意义(P<0.05);观察组中显效率为22.2%(48/216),显著高于对照组16.4%(35/214),差异有统计学意义(P<0.05)。结论:中西医结合治疗NPDR临床疗效显著。
AIM： To investigate the clinical efficacy of combination therapy and calcium dobesilate treatment of non-proliferative diabetic retinopathy（NPDR）, and staging study. METHODS： A total of 235 patients（430 eyes）with diabetic retinopathy meeting the criteria from Jan.2014 to May 2015 were randomly divided into observation group and control group according to the admission time. One hundred and ten cases（216 eyes）in the observation group were arranged to Compound Xueshuantong Capsule（a traditional Chinese medicine）with Calcium Dobesilate therapy, 125 cases（214 eyes）in the control group were arranged with Calcium Dobesilate treatment. The visual acuity, intraocular pressure, and retinal conditions were used to assess the clinical efficacy in two groups. RESULTS： The total effective rate was 90.3% in observation group（195 eyes / 216 eyes）, which was significantly higher than control group 72.9%（156 eye / 214 eyes）（P〈0.05）. The significant efficiency was 22.2%（48 eyes/216 eyes）in observation group, which was significantly higher than control group 16.4%（35 eyes/214 eyes）（P〈0.05）. CONCLUSION： The combination of traditional Chinese and Western medicine in the treatment of non-proliferative diabetic retinopathy clinical curative effect is remarkable.
出处
《国际眼科杂志》
CAS
2017年第1期148-150,共3页
International Eye Science
关键词
复方血栓通
羟苯磺酸钙
非增殖期糖尿病视网膜病变
Compound Xueshuantong Capsule
calcium dobesilate
non-proliferative diabetic retinopathy
